The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AVALYN PHARMACEUTICALS INC COM SHS 05348Y105 74,675,860 2,268,404 SH SOLE 2,268,404 0 0
GROVE COLLABORATIVE HOLD INC COM CL A 39957D201 4,031,371 3,225,097 SH SOLE 3,225,097 0 0
MBX BIOSCIENCES INC COM 55287L101 117,925,692 2,136,335 SH SOLE 2,136,335 0 0
OMADA HEALTH INC COM 68170A108 55,555,450 2,531,000 SH SOLE 2,531,000 0 0
ONDAS INC COM NEW 68236H204 128,560 15,602 SH SOLE 15,602 0 0
SNOWFLAKE INC COM SHS 833445109 29,213,037 114,786 SH SOLE 114,786 0 0
ZENAS BIOPHARMA INC COM 98937L105 46,660,673 1,838,482 SH SOLE 1,838,482 0 0